Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-26 @ 1:26 AM
Study NCT ID:
NCT00394433
Status:
COMPLETED
Last Update Posted:
2017-08-01
First Post:
2006-10-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-31
First Submit QC Date:
None
Study First Post Date:
2006-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-26
Results First Submit QC Date:
None
Results First Post Date:
2017-01-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-05
Last Update Post Date:
2017-08-01
Last Update Post Date Type:
ACTUAL